Apeloa Pharmaceutical Co Ltd
SZSE:000739
Apeloa Pharmaceutical Co Ltd
Cash from Operating Activities
Apeloa Pharmaceutical Co Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
A
|
Apeloa Pharmaceutical Co Ltd
SZSE:000739
|
Cash from Operating Activities
¥1B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
Cash from Operating Activities
¥4.2B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
2%
|
CAGR 10-Years
21%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Cash from Operating Activities
¥3.1B
|
CAGR 3-Years
9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Cash from Operating Activities
¥2.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
19%
|
CAGR 10-Years
22%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Cash from Operating Activities
¥8.7B
|
CAGR 3-Years
61%
|
CAGR 5-Years
26%
|
CAGR 10-Years
21%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Cash from Operating Activities
¥3.3B
|
CAGR 3-Years
1%
|
CAGR 5-Years
30%
|
CAGR 10-Years
12%
|
See Also
What is Apeloa Pharmaceutical Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
1B
CNY
Based on the financial report for Dec 31, 2023, Apeloa Pharmaceutical Co Ltd's Cash from Operating Activities amounts to 1B CNY.
What is Apeloa Pharmaceutical Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
4%
Over the last year, the Cash from Operating Activities growth was -22%. The average annual Cash from Operating Activities growth rates for Apeloa Pharmaceutical Co Ltd have been -1% over the past three years , 4% over the past five years .